DIFFERENTIAL DIAGNOSTICS OF CLINICALLY IMPORTANT ORGANIC PATHOLOGY AND IRRITABLE BOWEL SYNDROME
https://doi.org/10.51523/2708-6011.2009-6-3-7
Abstract
The topical question of present-day gastroenterology is the search for simple and noninvasive methods, which could disclose organic bowels pathology and determine the indications for the subsequent deep examination of patients. The research aim was to study diagnostic possibilities of faecal stoolprotectine and immunochemical test, including their combined application in differential diagnostics of clinically important organic and functional bowels pathology. 165 patients with clinically important organic bowels pathology and 93 patients with irritable bowel syndrome have been examined. It has been proved, that considering the diagnostic importance in revealing clinically important organic bowels pathology, the faecal stoolprotectine exceeds: the immunochemical test (0,87; CO: 0,02), anxiety syndrome (0,78; CO: 0,03, p < 0,01) and erythrocyte sedimentation rate (0,74; CO: 0,03, Z = 5,75, p < 0,01). The combined application of the faecal stoolprotectine and immunochemical test allows to raise the test sensitivity up to 96,1 % (95 % 91,8/98,6).
References
1. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma / J. Tibble [et al.] // Gut. - 2001. - Vol. 49, № 3. - P.402-408.
2. Kristinsson, J. Fecal calprotectin concentration in patients with colorectal carcinoma // J. Kristinsson // Dis. Colon Rectum. - 1998. - № 41. - Р. 316-321.
3. Fecal Calprotectin as a Marker in Differentiating Irritable Bowel Syndrome from Organic Intestinal Disease [Electronic recourse] / S. E. Saadany [et al.] // Mode of access: http://knol.google.com/k/sherif-el-saadany/ fecal-calprotectin-as-a-marker-in/i2p6c6e8rrui/7#. - Date of access: 12.06.2009.
4. Microalbuminuria correlates with intestinal histopathological grading in patients with inflammatory bowel disease / N. Mahmud [et al.] // Gut. - 1996. - Vol. 38, № 1. - Р. 99-103.
5. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders / А. Р. Poullis [et al.] // Eur. J. Gastroenterol. Hepatol. - 2002. - Vol. 14, № 4. - Р. 409-412.
6. Use of surrogate markers of intestinal inflammation and Rome criteria to distinguish organic from non-organic intestinal disease / J. A. Tibble [et al.] // Gastroenterology. - 2002. - Vol. 123, №.2. - P. 450-460.
7. Evaluation of patients who meet clinical criteria for irritable bowel syndrome В.А. Tolliver [et al.] // Am. J. Gastroenterol. - 1994. - Vol. 89, № 2. - Р. 176-178.
8. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome / S. J. Vanner [et al.] // Am. J. Gastroenterol. - 1999. - № 94. - Р. 2912-2917.
9. Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia / J. Hammer [et al.] // Gut. - 2004. - № 53. - Р. 666-672.
10. Red Flag Symptom Exclusions in the Diagnosis of IBS / W. E. Whitehead [et al.] // Alim. Pharm.& Ther. - 2006. - Vol. 24, № 1. - Р. 137-146.
11. Краткое руководство по гастроэнтерологии / В. Т. Ивашкин [и др.]; под ред. В. Т. Ивашкина, С. И. Рапопорта, Ф. И. Комарова. - М.: ООО «М-Вести», 2001. - 457 с.
12. Diagnostic Accuracy of Fecal Calprotectin Assay in Distinguishing Organic Causes of Chronic Diarrhea from Irritable Bowel Syndrome: A Prospective Study in Adults and Children / A. Carroccio [et al.] // Clinical Chemistry. - 2003. - № 49. - Р. 861-867.
13. Скрининг колоректального рака (литературный обзор) / Е. И. Михайлова [и др.] // Проблемы экологии и здоровья. - 2005. - № 3(5). - Р. 77-85.
Review
For citations:
Mihailova E.I. DIFFERENTIAL DIAGNOSTICS OF CLINICALLY IMPORTANT ORGANIC PATHOLOGY AND IRRITABLE BOWEL SYNDROME. Health and Ecology Issues. 2009;(3):35-41. (In Russ.) https://doi.org/10.51523/2708-6011.2009-6-3-7
Views: 242
Email this article 